# Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal

> **NCT03746327** · PHASE4 · COMPLETED · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 30 (actual)

## Conditions studied

- Prostheses Infection

## Interventions

- **DRUG:** Sivextro 200 milligrams Oral Tablet

## Key facts

- **NCT ID:** NCT03746327
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-13
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-03-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03746327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03746327, "Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03746327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*